<< Back
Mar 03, 2015

Zosano Pharma to Present at the 27th Annual ROTH Conference

FREMONT, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN) announced today that Vikram Lamba, Chief Executive Officer, will provide a company overview at the 27th Annual ROTH Conference on March 9, 2015. The presentation will take place at 10:00 a.m. PT at the Ritz Carlton Hotel in Laguna Niguel, California.

To access the live webcast and subsequent archived recordings for the presentation, please visit the Zosano website at www.zosanopharma.com. Under the "Investors" tab, select the link to "Events & Presentations."

About Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications. Zosano's microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections. Zosano's microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies. Learn more at www.zosanopharma.com.

CONTACT: Corporate Contact:

         Vikram Lamba

         Chief Executive Officer, Zosano




         Media Contact:

         Jamie Lacey-Moreira